Vascular-Targeted Therapies in Oncology
List of Contributors.
1 – Tumor Vasculature: a Target for Anticancer Therapies (Dietmar W. Siemann).
2 – Abnormal Microvasculature and Defective Microcirculatory Function in Solid Tumors (Peter Vaupel).
3 – The Role of Microvasculature in Metastasis Formation (Oliver Stöltzing, Lee M. Ellis).
4 – Development of Agents that Selectively Disrupt Tumor Vasculature: a Historical Perspective(David Chaplin, Sally A. Hill).
5 – Morphologic Manifestations of Vascular-Disrupting Agents in Preclinical Models (Mumtaz V. Rojiani, Amyn Rojiani).
6 – Molecular Recognition of the Colchicine Binding site as a Design Paradigm for the Discovery and Development of Vascular-Disrupting Agents (Kevin G. Pinney).
7 – Combined Modality Approaches Using Vascular-Disrupting Agents (Wenyin Shi, Michael R. Horsman, Dietmar W. Siemann).
8 – Vascular-Targeting Therapies and Hyperthermia (Michael R. Horsman, Rumi Murata).
9 – Flavones and Xanthenones as Vascular-Disrupting Agents (Bronwyn Siim, Bruce Baguley).
10 – Targeting Inside-Out Phospholipids on Tumor Blood Vessels in Pancreatic Cancer (Adam W. Beck, Rolf Brekken, Philip E. Thorpe, PhD).
11 – Cadherin Antagonists as Vascular-Targeting Agents (Orest Blaschuk, Tracey M. Rowlands).
12 – Alphastatin: a Pluripotent Inhibitor of Activated Endothelial Cells (Carolyn A. Staton, Claire Lewis)
13 – Cationic Lipid Complexes to Target Tumor Endothelium (Uwe Michaelis, Michael Teifel).
14 – Development of Vascular-Targeted Cancer Gene Therapy (Graeme J. Dougherty, Peter D. Davis, Shona T. Dougherty).
15 – Vascular-Disrupting Strategies Combined with Bacterial Spores Targeting Hypoxic Regions of Solid Tumors (G-One Ahn, J. Martin Brown).
16 – Imaging the Effects of Vascular-Targeting Agents (Susan M. Galbraith).
17 – Clinical Progress in Tumor Vascular-Disrupting Therapies (Andy Gaya, Gordon Rustin).
18 – Use of Vascular-Disrupting Agents in Non-Oncology Indications (Joseph C. Randall, Scott Young).